Intrinsiqq
Kamada Ltd. logo

Kamada Ltd. Insider Trading

KMDA

Compare
Last 12 months

Insiders sold $1.65M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director David Tsur sold $1.46M on Sep 9, 29% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market
−$1.65M
0 buys · 2 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 1
executives and directors
Last open-market buy
None
in the last two years

Get an email when KMDA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 14No plan
    David Tsur
    Director · sold 22,827 at $8.18
    187K
    5.3% of stake
  • Sep 7 – 9No plan
    David Tsur
    Director · sold 177,173 at avg $8.26
    $1.46M
    29% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch KMDA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Drug Manufacturers - Specialty & Generic · Pick stocks to compare with KMDA

CompareIntrinsic value
HNSA.XSTOHansa Biopharma AB
€3.91-7.13%26
SEDANA.XSTOSedana Medical AB
€0.72-4.40%48
GENT.XOSLGentian Diagnostics ASA
€3.63-0.55%52
OSSD.XSTOOssDsign AB
€0.22-8.82%40
OXB.XLONOxford Biomedica plc
£4.89-4.68%26
ALERS.XPAREurobio Scientific S.A.
€26.40+0.00%38
BINV.XSTOBioInvent International AB
€0.19-17.20%10
IDIA.XSWXIdorsia Ltd
CHF 3.66-2.87%30

Held by ETFs

KMDA is in 3 US ETFs. The largest of them, with KMDA's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing KMDA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.